The preparation method of tenofovir disoproxil fumarate intermediate

A phosphoric acid and system technology, applied in the field of medicine, can solve problems such as difficulty in stirring, and achieve the effects of solving difficulty in stirring, realizing industrialized production and simple preparation process

Active Publication Date: 2015-10-07
SHENZHEN KEXING PHARM CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0018] The present invention mainly solves the problem of intermediate one in the production of tenofovir disoproxil fumarate, i.e. 9-[(R)-2-[[diethoxy]phosphoric acid]methoxyl]propyl] Adenine, the technical problem of difficult stirring in the preparation process, making it suitable for industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The preparation method of tenofovir disoproxil fumarate intermediate
  • The preparation method of tenofovir disoproxil fumarate intermediate
  • The preparation method of tenofovir disoproxil fumarate intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Embodiment 1: the preparation of intermediate one

[0040] Add 10.00kg of starting materials and 40L of N-methylpyrrolidone into a 100L reactor, and slowly add 15kg of magnesium tert-butoxide under uniform stirring. Start heating, and start to add 20 kg of diethyl p-toluenesulfonyloxymethylphosphonate dropwise after the temperature rises to 70°C. After the addition is complete, keep the temperature at about 79°C for continuous reaction, and the basic reaction of the starting materials is detected by TLC. Stop heating and cool to room temperature naturally.

[0041]Add acetic acid to the system to adjust the pH to 7.0, and stir for 30 minutes to dissolve the system. Slowly add the reaction solution into 300L ethyl acetate, stir rapidly, a large amount of solids precipitate out, continue to stir for half an hour after the addition, and centrifuge. The filter cake was beaten with 50L of dichloromethane and centrifuged. After the filtrates were combined, they were concen...

Embodiment 2

[0042] Embodiment 2: the preparation of intermediate two

[0043] Add the N-methylpyrrolidone solution of intermediate 1 into a 100L reaction kettle, add 18.5kg of bromotrimethylsilane dropwise with stirring, and finish the dropwise addition in about one hour, then heat to 75°C, and stir to react. After the end point of the reaction was controlled by TLC to determine the completion of the raw materials, the temperature was lowered to quench the reaction.

[0044] Slowly add 30L of water to the system, then wash with 20L×2 ethyl acetate, adjust the pH of the water layer to 3 with 40% NaOH solution, and slowly cool the system to 0-5°C and slowly stir for crystallization. After crystallization for 3 hours, centrifugation, the obtained solid was washed with 4 L of ice water, and the obtained solid was air-dried at 70° C. for 8 hours to obtain 9.6 kg of crude product. After the crude product was recrystallized with water, it was filtered and dried to obtain 8.5 kg of the refined p...

Embodiment 3

[0045] Embodiment 3: the preparation of tenofovir disoproxil

[0046] Add 30L of N-methylpyrrolidone, 8.5kg of tenofovir, 8.9kg of triethylamine and 7.5kg of tetrabutylammonium bromide into the reaction kettle in sequence, and after stirring for 20 minutes, start to raise the temperature to 50°C. Then, 22.5kg chloromethyl isopropyl carbonate was added dropwise rapidly from the constant pressure dropping funnel, and the reaction was stirred. The reaction was monitored by TLC, and when the reaction of the starting material was basically complete, the temperature was lowered to quench the reaction.

[0047] After cooling down, add 12L*2 cyclohexane to the system, stir and wash for 20min, and discard the cyclohexane in the upper layer after static separation. The N-methylpyrrolidone solution in the lower layer was transferred to a reaction kettle, 60L of water and 40L of ethyl acetate were added, stirred for 30 minutes, and then separated into layers, and the aqueous layer was ex...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the drug technology field, and particularly relates to a preparation method of a compound 9-[[(R)-2-[[diethoxy]phosphinyl] methoxy]propyl]adenine (I). The compound can be used for preparing an intermediate of tenofovir disoproxil fumarate (a chemical name: 9-[(R)-2-[[bis[[(isopropoxycarbonyl)oxy]methoxy]phosphinyl]methoxy]propyl]adenine fumarate).

Description

technical field [0001] The invention belongs to the technical field of medicines, in particular to the production of tenofovir disoproxil fumarate intermediate 9-[(R)-2-[[diethoxy]phosphate]methoxy]propyl]adenine Preparation. Background technique [0002] Tenofovir disoproxil fumarate, the chemical name is 9-[(R)-2-[[bis[[(isopropoxycarbonyl)oxy]methoxy]phosphoric acid]methoxy]propyl ] Adenine fumarate, the chemical structural formula is as follows: [0003] [0004] This product is a nucleotide anti-HIV reverse transcriptase inhibitor developed by Gilead Corporation of the United States. It was first approved for marketing in the United States on October 26, 2001, and has been approved for clinical use in more than 40 countries in the European Union, Japan, and South America. [0005] The chemical structural formula of tenofovir disoproxil is as follows: [0006] [0007] It is an intermediate for the preparation of tenofovir disoproxil fumarate. [0008] The chem...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07F9/6561C07C57/15C07C51/41
Inventor 何询何社辉张水华张英陈茂胜
Owner SHENZHEN KEXING PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap